-- Robex Resources (RBX.V) 周四宣布，已完成向澳大利亚上市公司 Predictive Discovery (ASX: PDI) 的出售交易，交易金额为 19.8 亿加元。 两家公司在一份联合声明中表示，该交易旨在“打造一家领先的西非黄金生产和开发公司，目标是到 2029 年实现年产黄金超过 40 万盎司”。 根据交易条款，Predictive Discovery 收购了 Robex 的所有股份，Robex 股东每持有 1 股 Robex 股份可获得 7.862 股 PDI 股份。声明称，Robex 将于 4 月 20 日从多伦多证券交易所创业板退市，而 PDI 将继续在澳大利亚证券交易所上市，并计划于 4 月在多伦多证券交易所开始交易。 Robex 股票在多伦多证券交易所收盘价为 7.11 加元，与前一日持平。
Related Articles
Asia
American Uranium Launches Nearly AU$3 Million Entitlement Offer
American Uranium (ASX:AMU) launched a pro rata non-renounceable rights issue to raise around AU$2.6 million before costs, offering eligible shareholders in Australia, New Zealand, and Canada one new share for every six held at AU$0.12 per share, according to a Friday filing with the Australian bourse.The participants will also receive one free attaching option for every two new shares subscribed, exercisable at AU$0.16 and expiring on June 30, 2029, although these options will not be listed on the Australian Securities Exchange, per the filing.New shares will rank equally with existing shares, while shareholders may take up all, part, or none of their entitlement, with any shortfall potentially allocated to exempt investors at directors' discretion within three months of closing, the filing said.The proceeds will be used to fund permitted infill and expansion drilling, as well as hydrogeological and metallurgical programs at Lo Herma in Wyoming, US, in preparation for the planned third quarter scoping study, the filing added.
$ASX:AMU
Asia
AMP Accelerated Momentum Across Core Business Units in Q1, Jefferies Says
AMP (ASX:AMP) reported "encouraging" first-quarter results as momentum accelerated across its core business units, and AMP Bank recorded only a minor decrease in loan balances from the linked quarter, Jefferies said in a Thursday note.The company's North wealth management platform saw a robust AU$1.1 billion of new inflows, representing the fourth consecutive quarter of net inflows topping the AU$1 billion mark. The Superannuation and Investments division posted "a continued and meaningful improvement" as net cash outflows contracted to AU$80 million, Jefferies said.In its international businesses, the outlook for AMP's China Life ventures is buoyed by structural demographic tailwinds, while AMP New Zealand performed well with positive new cash inflows of AU$41 million in the quarter, the equity research firm said.The company's AU$150 million on-market buyback is now included in forecasts, which Jefferies estimates to be around 4% accretive. Including overall forecasting adjustments, the firm's EPS forecasts for AMP increase 6% for 2026 and 8% for 2027.Jefferies maintained a buy rating on AMP and raised its price target on the company's shares to AU$1.75 from AU$1.50.
$ASX:AMP
Asia
Orthocell Says First Surgical Case Using Nerve Repair Product in US Department of Defense Hospital Network Completed
Orthocell (ASX:OCC) said that a surgery at a military base hospital in Ohio within the US Department of Defense/Veterans Affairs hospital network was the first surgical case using its nerve repair product, Remplir, according to a Friday Australian bourse filing.The company said that this represented an important step in its US commercialization strategy.
$ASX:OCC